MS

Marion Subklewe

AM Amgen: 2 patents #57 of 505Top 15%
Overall (2021): #132,722 of 548,734Top 25%
2
Patents 2021

Issued Patents 2021

Patent #TitleCo-InventorsDate
11053318 Administration of a bispecific construct binding to CD33 and CD3 for use in a method for the treatment of myeloid leukemia Gerhard Zugmaier, Peter Kufer, Roman Kischel, Christina Heitmueller 2021-07-06
10933132 Combination of epigenetic factors and bispecific compounds targeting CD33 and CD3 in the treatment of myeloid leukemia Roland Walter, Christina Krupka 2021-03-02